Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating expenses:
Research and development	$ 6,609	$ 3,112
General and administrative	2,927	3,436
Total operating expenses	9,536	6,548
Operating loss	(9,536)	(6,548)
Other income (expense)
Interest income	226	24
Interest expense	(689)	(478)
Other income (expense), net	(15)	(686)
Change in fair value of earn-out liability	0	10,757
Total other income (expense)	(478)	9,617
Net income (loss)	(10,014)	3,069
Comprehensive income (loss):
Net income (Loss)	(10,014)	3,069
Other comprehensive income (loss)	19	(50)
Comprehensive income (loss)	$ (9,995)	$ 3,019
Net income (loss) per share attributable to common shareholders:
Net income (loss) per share - Basic	$ (0.24)	$ 0.08
Net income (loss) per share - diluted	$ (0.24)	$ 0.07
Weighted-average common shares outstanding:
Weighted average common shares outstanding - basic	42,001,147	40,848,325
Weighted average common shares outstanding - diluted	42,001,147	43,382,444